Hyperglycemia leads to SGLT2 overexpression in human cardiomyocytes in vitro and in vivo, potentially resulting in systolic and diastolic dysfunction and, ultimately, heart failure, particularly in patients with DM6. Here, SLC5A2 is linked to heart failure.